A small molecule screening carried out by Oku et al. in 2015 showed that dasatinib, statins, and pazopanib inhibited the nuclear localization of YAP/TAZ and TEAD-dependent transcription, and induced YAP/TAZ phosphorylation in breast cancer cell lines [192]. Here, YAP1 is linked to breast carcinoma.